Bavarian Nordic A/S, of Copenhagen, said a new study started testing the Ebola prime-boost vaccine regimen that combines Bavarian's MVA-BN Filo vaccine with the Ad26.Zebov vaccine from Crucell Holland B.V., one of the Janssen Pharmaceutical companies of New Brunswick, N.J.-based Johnson & Johnson.